Company intelligence / Profile preview

A1 Group

Turkey

Ownership: Private
Development stage: Other

Overview

A1 Life Sciences specializes in manufacturing a broad portfolio of in vitro research and diagnostic products, including six Covid-19 diagnostic products, and supplies lab solutions globally across 55 countries, with a strong client-centric approach and sizable production capacity.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic productIn vitro diagnosticLab solution
Industry: Molecular Diagnostics

Partnerships

Collaborates with public and private sector organizations for diagnostic solutions supply

Beyond the preview

Go deeper on A1 Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A1 Group.

Explore the full profile